GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for aspartate carbamoyltransferase (B2T0I7)

Analyse AlphaFold monomer V2.0 prediction for aspartate carbamoyltransferase (B2T0I7) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2T0I7
Type
protein
Length
341 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x55F166d9F6A3981E60dDA03De65e7EbdD73842e2
Molecule
Aspartate carbamoyltransferase
UniProt
B2T0I7
Pockets
2 · best druggability 0.64

Structure

1 distinct chain · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAspartate carbamoyltransferaseprotein34142% helix, 16% strandB2T0I7

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11830.640.8529empty
2610.360.7915empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.